Literature DB >> 29581554

Heart rate reduction decreases central blood pressure in sick sinus syndrome patients with a permanent cardiac pacemaker.

Tuuli Teeäär1,2,3, Martin Serg4,5,6, Kaido Paapstel4,7, Jaak Kals7,8, Mart Kals9, Mihkel Zilmer7, Jaan Eha4,6, Priit Kampus4,5.   

Abstract

Increased resting heart rate (HR) contributes to higher cardiovascular mortality and morbidity in the healthy as well as in people with cardiovascular diseases, possibly due to elevated blood pressure (BP) among other mechanisms. Data on the relationship between HR and central (aortic) BP remains controversial, however, and concerning β-blockers, it has been proposed that pharmacological HR lowering is associated with augmentation of central BP. We aimed to study the role of pharmacologically unaffected HR on central BP indices in sick sinus syndrome patients with a permanent cardiac pacemaker in the HR range from 40 to 90 bpm. We included 27 subjects (mean age 65.8 ± 9.5 years, 12 men) with a dual-chamber pacemaker implanted due to sick sinus syndrome. We determined central hemodynamic indices noninvasively during an atrial pacing mode at low (40 bpm), middle (60 bpm), and high (90 bpm) HR levels with an oscillometric cuff-based device (Sphygmocor XCEL). There was no difference in central systolic BP at the middle versus the high HR level (mean 121.2 ± 13.0 and 121.2 ± 12.1 mmHg, respectively, P = 0.9), but at the low HR level, it was significantly lower than at the middle HR level (mean 117.2 ± 13.1 and 121.2 ± 13.0 mmHg, P < 0.01). Our acute study provides evidence to suggest that at a HR of <60 bpm, sick sinus syndrome patients may have a lower central BP than at a higher HR, despite the proposed augmenting effects of low HR on central BP.

Entities:  

Mesh:

Year:  2018        PMID: 29581554     DOI: 10.1038/s41371-018-0051-4

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  30 in total

Review 1.  Association of Central Versus Brachial Blood Pressure With Target-Organ Damage: Systematic Review and Meta-Analysis.

Authors:  Anastasios Kollias; Styliani Lagou; Maria Elena Zeniodi; Nadia Boubouchairopoulou; George S Stergiou
Journal:  Hypertension       Date:  2015-11-23       Impact factor: 10.190

2.  Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis.

Authors:  Dongfeng Zhang; Xiaoli Shen; Xin Qi
Journal:  CMAJ       Date:  2015-11-23       Impact factor: 8.262

3.  The pulse of cardiology: quo vadis?

Authors:  Michael F O'Rourke; Christopher S Hayward
Journal:  J Am Coll Cardiol       Date:  2009-08-18       Impact factor: 24.094

4.  Aortic augmentation index in endurance athletes: a role for cardiorespiratory fitness.

Authors:  Joshua Denham; Nicholas J Brown; Maciej Tomaszewski; Bryan Williams; Brendan J O'Brien; Fadi J Charchar
Journal:  Eur J Appl Physiol       Date:  2016-06-08       Impact factor: 3.078

5.  The relation of heart rate to cardiovascular dynamics. Pacing by atrial electrodes.

Authors:  E Stein; A N Damato; B D Kosowsky; S H Lau; J W Lister
Journal:  Circulation       Date:  1966-06       Impact factor: 29.690

Review 6.  Effects of β-Blockers With and Without Vasodilating Properties on Central Blood Pressure: Systematic Review and Meta-Analysis of Randomized Trials in Hypertension.

Authors:  Giacomo Pucci; Maria Giovanna Ranalli; Francesca Battista; Giuseppe Schillaci
Journal:  Hypertension       Date:  2015-11-30       Impact factor: 10.190

7.  Heart rate as marker of sympathetic activity.

Authors:  G Grassi; S Vailati; G Bertinieri; G Seravalle; M L Stella; R Dell'Oro; G Mancia
Journal:  J Hypertens       Date:  1998-11       Impact factor: 4.844

8.  Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.

Authors:  Jean-Guillaume Dillinger; Vincent Maher; Cristiana Vitale; Patrick Henry; Damien Logeart; Stephane Manzo Silberman; Guillaume Allée; Bernard I Levy
Journal:  Hypertension       Date:  2015-09-21       Impact factor: 10.190

Review 9.  When an Increase in Central Systolic Pressure Overrides the Benefits of Heart Rate Lowering.

Authors:  Franz H Messerli; Stefano F Rimoldi; Sripal Bangalore; Chirag Bavishi; Stephane Laurent
Journal:  J Am Coll Cardiol       Date:  2016-08-16       Impact factor: 24.094

10.  Comparison of Central Blood Pressure Estimated by a Cuff-Based Device With Radial Tonometry.

Authors:  Xiaoqing Peng; Martin G Schultz; Walter P Abhayaratna; Michael Stowasser; James E Sharman
Journal:  Am J Hypertens       Date:  2016-06-17       Impact factor: 2.689

View more
  2 in total

1.  Atenolol's Inferior Ability to Reduce Central vs Peripheral Blood Pressure Can Be Explained by the Combination of Its Heart Rate-Dependent and Heart Rate-Independent Effects.

Authors:  Tuuli Teeäär; Martin Serg; Kaido Paapstel; Mare Vähi; Jaak Kals; John R Cockcroft; Mihkel Zilmer; Jaan Eha; Priit Kampus
Journal:  Int J Hypertens       Date:  2020-04-26       Impact factor: 2.420

2.  Atrial fibrillation is associated with increased central blood pressure and arterial stiffness.

Authors:  Priit Pauklin; Jaan Eha; Kaspar Tootsi; Rein Kolk; Rain Paju; Mart Kals; Priit Kampus
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-07-12       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.